Archives of Clinical Infectious Diseases
Infectious Diseases and Tropical Medicine Research Center, SBUMS
OpenAlex
Works that cite this article, indexed by OpenAlex.
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Inflammopharmacology 30(3) (2022)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Luay M. Alkazmi; Ola A. Habotta; Gaber El‐Saber Batiha
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Pulmonary Pharmacology & Therapeutics 67 (2021)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Naeem F. Qusty; Natália Alves Martins; Gaber El‐Saber Batiha
COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery
Asian Pacific Journal of Reproduction 9(3) (2020)
Hayder Mutter Al-Kuraishy; Thabat Jumaah Al-Maiahy; Ali Ismail Al-Gareeb; Rasha Abdul-Ridha Musa; ZaidH Ali
COVID-19 and phosphodiesterase enzyme type 5 inhibitors
Journal of Microscopy and Ultrastructure 8(4) (2020)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Marwa S. Al‐Niemi; Ali K. Albuhadily; Nasser A. Al‐Harchan; Claire Lugnier
Macrolides and COVID-19: An optimum premise
Biomedical and Biotechnology Research Journal (BBRJ) 4(3) (2020)
Hayder Mutter Al-Kuraishy; Marwa Salih Al-Naimi; Claire Lungnier; Ali Ismail Al-Gareeb
Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment
NeuroMolecular Medicine 27(1) (2025)
Saad Misfer Alqahtani; Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Ali K. Albuhadily; Athanasios T. Alexiou; Marios Papadakis; Loah R. Hemeda; Safaa A. Faheem; Gaber El‐Saber Batiha
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Frontiers in Public Health 9 (2021)
Amany Magdy Beshbishy; Victor Baba Oti; Diaa E. Hussein; Ibrahim F. Rehan; Oluyomi Stephen Adeyemı; Nallely Rivero-Pérez; Adrián Zaragoza-Bastida; Muhammad Ajmal Shah; Khaled Abouelezz; Helal F. Hetta; Natália Alves Martins; Gaber El‐Saber Batiha
Antidepressants and type 2 diabetes: highways to knowns and unknowns
Diabetology & Metabolic Syndrome 15(1) (2023)
Nahi Sabih Alruwaili; Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Ali K. Albuhadily; Amany Elsayed Ragab; Ahmad Awad Alenazi; Athanasios T. Alexiou; Marios Papadakis; Gaber El‐Saber Batiha
SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Immunity Inflammation and Disease 11(5) (2023)
Hayder Mutter Al-Kuraishy; Nawar R. Hussein; Marwa S. Al‐Niemi; Esraa Hammadi Fahad; Ali K. Albuhadily; Ali Ismail Al-Gareeb; Sadiq Mohammed Al-Hamash; Christos Tsagkaris; Marios Papadakis; Athanasios T. Alexiou; Gaber El‐Saber Batiha
The Important Role of Interleukin-2 in COVID-19
Journal of Immunology Research 2023 (2023)
Leila Ghanbari Naeini; Laleh Abbasi; Farzaneh Karimi; Pajman Kokabian; Fahimeh Abdi Abyaneh; Delaram Naderi
Pregnancy and COVID-19: high or low risk of vertical transmission
Clinical and Experimental Medicine 23(4) (2022)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Nisreen Khalid Aref Albezrah; Haitham Ahmed Bahaa; Maisra Mohammed El-Bouseary; Athanasios T. Alexiou; Shatha Hallal Al-Ziyadi; Gaber El‐Saber Batiha
The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted
IntechOpen eBooks (2020)
Hayder Mutter Al-Kuraishy; Marwa S. Al‐Niemi; Nawar R. Hussain; Ali Ismail Al-Gareeb; Nasser A. Al‐Harchan; Azhar H. Al-Kurashi
Acute kidney injury and COVID-19
The Egyptian Journal of Internal Medicine 33(1) (2021)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb
Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19
Scientific Reports 13(1) (2023)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Sumaiah J. Alarfaj; Rasha Khalifah Al-Akeel; Hani Saleh Faidah; Maisra Mohammed El-Bouseary; Jean‐Marc Sabatier; Michel MDW DE WAARD; Thanaa Ahmed El-Masry; Gaber El‐Saber Batiha
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Cell Stress and Chaperones 28(6) (2023)
Rabab S. Hamad; Hayder Mutter Al-Kuraishy; Athanasios T. Alexiou; Marios Papadakis; Eman Ahmed; Hebatallah M. Saad; Gaber El‐Saber Batiha
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Journal of Biochemical and Molecular Toxicology 38(1) (2023)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Omayma A. Eldahshan; Yasmin M. Abdelkhalek; Magdy El dahshan; Eman Ahmed; Jean‐Marc Sabatier; Gaber El‐Saber Batiha
Autophagy modulators in type 2 diabetes: A new perspective
Journal of Diabetes 16(12) (2024)
Ayah Talal Zaidalkilani; Hayder Mutter Al-Kuraishy; Esraa Hammadi Fahad; Ali Ismail Al-Gareeb; Yaser Hosny Ali Elewa; Mahmoud Hosny Zahran; Athanasios T. Alexiou; Marios Papadakis; Ammar M. AL-Farga; Gaber El‐Saber Batiha
COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
Current Molecular Pharmacology 16(4) (2022)
Pranav Kumar Prabhakar; Gaber El‐Saber Batiha; Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Gomaa Mostafa‐Hedeab; Rupal Dubey
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19
Drug Metabolism and Personalized Therapy (2023)
Ryan Varghese; Gargi Digholkar; Jainam Karsiya; Sahil Salvi; Jeenam Shah; Dileep Kumar; Rohit Sharma
Immunological interactions in helminths‐SARS CoV ‐2 coinfection: Could old enemy be a friend today?
Parasite Immunology 45(5) (2023)
Mohammed Alrouji; Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Heba Elhadad; Athanasios T. Alexiou; Marios Papadakis; Hanan A. Ogaly; Ahmed M. El‐Gazzar; Gaber El‐Saber Batiha
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19
Drug Metabolism and Personalized Therapy 38(4) (2023)
Ryan Varghese; Gargi Digholkar; Jainam Karsiya; Sahil Salvi; Jeenam Shah; Dileep Kumar; Rohit Sharma
Cotrimoxazole and teicoplanin in the management of Covid-19: Pleiotropic effects, shadows and lights
CURRENT MEDICAL AND DRUG RESEARCH 4(02) (2020)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Ali K. RaAl-Buhadilyj
Unraveling COVID-19: A Global Health Crisis and Ongoing Research
Futuristic Biotechnology (2023)
Osama Alam; Muhammad Ahmad; Munib Qureshi; Marina Gul; Naveed Ahmed Khan; Abdul Samad; Zewran Khan; Syed Atiq; Arsalan Iqbal; Asim Ullah
Brain injury and SARS-CoV-2 infection: Bidirectional pathways
CURRENT MEDICAL AND DRUG RESEARCH 4(02) (2020)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Marta Chagas Monteiro; Hanan J. Al-Saiddy
A cross-sectional pilot study on COVID-19 disease pattern, recovery status and effect of co-morbidities in Bangladesh
African Journal of Pharmacy and Pharmacology 15(5) (2021)
Monirul Islam Md.; Saimon Shahriar; Fahima Jannat Koly; Shaila Kabir; Asad Chowdhury Abu; Jakir Ahmed Choudhury; Rafat Tahsin; Shah Amran Md.
Covid-19 and Iraq: The exponential epidemic
JOURNAL OF CONVENTIONAL KNOWLEDGE AND HOLISTIC HEALTH 4(02) (2020)
Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb; Marta Chagas Monteiro; Heiam N. Hussein
Study Effect of Some Atmospheric Elements on COVID-19 Infections in Iraq
Al-Mustansiriyah Journal of Sciences 32(2) (2021)
Ahmed F. Hassoon; Hazim H. Hussain; Nagham T. Ibraheem
COVID-19 and risk of cardiomyocyte injury: The prevailing scenario
CURRENT MEDICAL AND DRUG RESEARCH 5(01) (2021)
Marwa S. Al‐Niemi; Nawar R. Hussain; Hayder Mutter Al-Kuraishy; Ali Ismail Al-Gareeb
The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer
CURRENT MEDICAL AND DRUG RESEARCH 5(01) (2021)
Hayder Mutter Al-Kuraishy; Marwa S. Al‐Niemi; Nawar R. Hussain; Ali Ismail Al-Gareeb; Claire Lugnier
Brain and Peripheral Neuronal Injury in Covid-19: The Panorama and Dispute
Applied Medical Research (2021)
Hayder Mutter Al-Kuraishy
Covid-19 and Angiotensin Converting Enzyme 2(ACE2)
Applied Medical Research (2021)
Hayder Mutter Al-Kuraishy